Robert Taub — Email, Phone & Partners

Overview

Robert Taub is an entrepreneur and investor with over four decades of experience in the biopharmaceutical and medical technology industries. He co-founded Octapharma AG in 1983, a Swiss plasma fractionation and pharmaceutical company, and managed it until 1995. In 1995, he founded Omrix Biopharmaceuticals, Inc., serving as CEO and leading the company through its NASDAQ IPO and eventual acquisition by Johnson & Johnson in 2008. In 2009, he co-founded Nyxoah S.A., a company developing implantable devices for the treatment of obstructive sleep apnea, and has served as its Chairman since its inception. Mr. Taub holds a B.A. in Languages from the University of Antwerp and an MBA from INSEAD in Fontainebleau, France. Throughout his career, Mr. Taub has been actively involved in the development and commercialization of innovative medical treatments. His leadership at Omrix Biopharmaceuticals resulted in the successful launch of protein-based biosurgical and immunotherapy products, culminating in the company's acquisition by Johnson & Johnson. At Nyxoah S.A., he has overseen the development of implantable devices aimed at treating sleep apnea, contributing to advancements in medical technology. His strategic vision and commitment to healthcare innovation have been instrumental in the growth and success of these ventures. Mr. Taub's investment approach focuses on early-stage and growth-stage companies within the biopharmaceutical and medical device sectors. He seeks opportunities that align with his expertise in healthcare and his passion for improving patient outcomes. His active involvement in the companies he invests in, often taking on leadership roles such as Chairman, reflects his hands-on approach to fostering innovation and driving business growth. His diverse portfolio and successful track record underscore his reputation as a seasoned investor in the healthcare industry.

Investment Focus

Innovative medical technologies
Experienced management teams
Scalable business models
Strong market potential

Portfolio Companies

Octapharma AGOmrix Biopharmaceuticals, Inc.Nyxoah S.A.

Reach Robert Taub directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Robert Taub

What sectors does Robert Taub invest in?

Robert Taub invests in Healthcare, Pharmaceuticals, Medical Devices and Biotechnology, and is based in New York, United States. Robert Taub is listed as a angel investor in the ConnectSafely investor database.